MedTrace Logo

Does Tranexamic Acid Improve Visualization During Arthroscopic Rotator Cuff Repair

NCT04865380 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-05-03

No results posted yet for this study

Summary

This clinical trial examines whether intravenous preoperative administration of tranexamic acid (TXA) before arthroscopic rotator cuff repair (ARCR) can improve arthroscopic visualization during the procedure.

Conditions

  • Rotator Cuff Tears
  • Rotator Cuff Injuries
  • Subacromial Impingement
  • Subacromial Impingement Syndrome

Interventions

DRUG

Tranexamic Acid 100 MG/ML

1g IV x 1 dose of Tranexamic Acid administered preoperatively.

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Jeremy Reed, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2021-12-31
Completion
2022-04-30
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865380 on ClinicalTrials.gov